68363-44-0

Basic information

• Product Name: 2-(2-((2-benzhydrylphenyl)amino)thiazol-4-yl)-2-oxoacetic acid
• Synonyms: 2-(2-((2-benzhydrylphenyl)amino)thiazol-4-yl)-2-oxoacetic acid
• CAS NO: 68363-44-0
• Molecular Formula: C24H18N2O3S
• Molecular Weight: 414.485
• Mol File: 68363-44-0.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 2-(2-((2-benzhydrylphenyl)amino)thiazol-4-yl)-2-oxoacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-((2-benzhydrylphenyl)amino)thiazol-4-yl)-2-oxoacetic acid(68363-44-0)
• EPA Substance Registry System: 2-(2-((2-benzhydrylphenyl)amino)thiazol-4-yl)-2-oxoacetic acid(68363-44-0)

Safety Data

• Hazardous Substances Data: 68363-44-0(Hazardous Substances Data)

Usage

Uses

2-(2-Tritylamino-4-thiazolyl)glyoxylic Acid was used to prepare and stuyd the antibacterial activity of acetohydroxamoylethyliminoacetylcephalosporins.

Upstream product

• 64987-08-2 ethyl 2-(2-aminothiazol-4-yl)glyoxylate 
• 76-83-5 trityl chloride 
• 68363-43-9 ethyl 2-oxo-2-(2-(tritylamino)thiazol-4-yl)acetate 

Downstream Products

• 1026067-63-9 (6R,7R)-7-{2-{(Z)-3-[4-Benzhydryloxy-5-(4-methoxy-benzyloxy)-1-oxy-pyridin-2-yl]-isoxazol-5-ylmethoxyimino}-2-[2-(trityl-amino)-thiazol-4-yl]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 
• 1027958-86-6 (6R,7R)-7-{2-{(Z)-3-[4-Benzhydryloxy-5-(4-methoxy-benzyloxy)-1-oxy-pyridin-2-yl]-isoxazol-5-ylmethoxyimino}-2-[2-(trityl-amino)-thiazol-4-yl]-acetylamino}-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 
• 1026528-98-2 (6R,7R)-7-{2-{(Z)-3-[4-Benzhydryloxy-5-(4-methoxy-benzyloxy)-1-oxy-pyridin-2-yl]-isoxazol-5-ylmethoxyimino}-2-[2-(trityl-amino)-thiazol-4-yl]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 
• 1026003-88-2 (6R,7R)-7-{2-{(Z)-3-[4-Benzhydryloxy-5-(4-methoxy-benzyloxy)-1-oxy-pyridin-2-yl]-isoxazol-5-ylmethoxyimino}-2-[2-(trityl-amino)-thiazol-4-yl]-acetylamino}-3-chloromethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 
• 1026067-80-0 (6R,7R)-3-Acetoxymethyl-7-{2-{(Z)-3-[4-benzhydryloxy-5-(4-methoxy-benzyloxy)-1-oxy-pyridin-2-yl]-isoxazol-5-ylmethoxyimino}-2-[2-(trityl-amino)-thiazol-4-yl]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 
• 133076-31-0 p-methoxybenzyl 7-<(Z)-2-(2-tritylaminothiazol-4-yl)-2-(2-(3-diphenylmethoxy-4-pyridon-1-yl)-1-diphenylmethoxycarbonylethoxyimino)acetamido>-3-(1,2,3-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate 
• 133076-30-9 p-methoxybenzyl 7-<(Z)-2-(2-tritylaminothiazol-4-yl)-2-(3-(3-diphenylmethoxy-4-pyridon-1-yl)-3-diphenylmethoxycarbonylpropoxyimino)acetamido>-3-(1,2,3-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate 
• 133076-32-1 p-methoxybenzyl 7-<(Z)-2-(2-tritylaminothiazol-4-yl)-2-(2-(3-diphenylmethoxy-4-pyridon-1-yl)ethoxyimino)acetamido>-3-(1,2,3-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate 
• 114875-61-5 (Z)-2-(((1,5-bis(benzhydryloxy)-4-oxo-1,4-dihydropyridin-2-yl)methoxy)imino)-2-(2-(tritylamino)thiazol-4-yl)acetic acid 
• 73562-94-4 (Z)-2-(1-t-Butoxycarbonylcycloprop-1-oxyimino)-2-(2-tritylaminothiazol-4-yl)acetic acid 
• 159048-31-4 {(Z)-3-[4-Benzhydryloxy-5-(4-methoxy-benzyloxy)-1-oxy-pyridin-2-yl]-isoxazol-5-ylmethoxyimino}-[2-(trityl-amino)-thiazol-4-yl]-acetic acid 
• 136248-54-9 [(Z)-2,2-Dimethyl-benzo[1,3]dioxol-5-ylmethoxyimino]-[2-(trityl-amino)-thiazol-4-yl]-acetic acid 
• 941286-37-9 (Z)-3-acetyl-1-(4-methoxyphenyl)-8-(2-(tritylamino)thiazol-4-yl)-2,6-dioxa-3,7-diazanon-7-en-9-oic acid 
• 136018-98-9 (Z)-2-<<(tert-butoxycarbonyl)-(3,4-diacetoxyphenylthio)methoxy>imino>-2-(2-tritylamino-4-thiazolyl)acetic acid 

Relevant articles and documents

Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue

Based on the structural characteristics of aztreonam (AZN) and its target PBP3, a series of new monobactam derivatives bearing various substituents on oxime residue were prepared and evaluated for their antibacterial activities against susceptible and res

DEUTERATED O-SULFATED BETA-LACTAM HYDROXAMIC ACIDS AND DEUTERATED N-SULFATED BETA-LACTAMS

Provided herein are deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams, pharmaceutical compositions thereof and methods of treating infectious disease with deuterated compounds or pharmaceutical compositions thereof.

OXAMAZIN ANTIBIOTICS

Disclosed herein are oxamazin monobactam compounds and their use as antibiotics resistant to degradation by β-lactamases. Also disclosed are pharmaceutical compositions containing the compounds and methods of synthesis.